KRAS and colorectal cancer: In this retrospective study [29] were included 22 patients with 65 liver metastases due to colorectal cancer, and the patients were divided into two groups with KRAS mutation positive (+) (n: 10, 30 lesions) and the wild-type group (n: 12, 35 lesions).